New data independently confirms and extends laboratory findings and expands safety profile of ATH434 August 4, 2020August 16, 2022
Alterity Therapeutics to Present at the MST Access ‘Hidden Gems in Life Sciences’ Webinar June 13, 2024June 13, 2024
Alterity Therapeutics Announces Publication Demonstrating that ATH434 is Neuroprotective in Animal Model of Parkinsonian Disorder in the Journal of Parkinson’s Disease January 28, 2022August 16, 2022
